ZHOU Fen, ZHANG Yubin, XIAO Meifang. Analysis of Mycoplasma genitalium infection and drug resistance in Haikou area of Hainan Province[J]. Journal of Clinical Medicine in Practice, 2022, 26(7): 18-21. DOI: 10.7619/jcmp.20214298
Citation: ZHOU Fen, ZHANG Yubin, XIAO Meifang. Analysis of Mycoplasma genitalium infection and drug resistance in Haikou area of Hainan Province[J]. Journal of Clinical Medicine in Practice, 2022, 26(7): 18-21. DOI: 10.7619/jcmp.20214298

Analysis of Mycoplasma genitalium infection and drug resistance in Haikou area of Hainan Province

More Information
  • Received Date: October 31, 2021
  • Available Online: March 27, 2022
  • Published Date: April 14, 2022
  •   Objective  To analyze conditions of Mycoplasma genitalium infection and drug resistance in HaiKou area.
      Methods  A commercial kit was used to test Ureaplasma urealytium (Uu) and Mycoplasma humanum (Mh) as well as drug sensitivity in the secretions of 10 109 patients with suspected genital tract infections, and the results were statistically analyzed.
      Results  Mycoplasma was detected in the genital tract specimens of 3 491 patients(34.53%), with a higher rate of positivity in females (37.25%) than in males (12.94%). The patients positive for Mycoplasma were mainly in the age group of 21 to 40 years old. The positive rate of Uu infection was 32.04%, was 0.41% for Mh infection, and was 2.09% for Uu combined with Mh infection. The drug sensitivity test results showed that Mycoplasma was resistant to ciprofloxacin and 14 as well as 15 metacyclic macrolide antimicrobials, with the drug resistance rate of 90.24% and above, and the resistance rate to josamycin, doxycycline and minocycline were≤11.37%.
      Conclusion  Mycoplasma genitalium infections in Haikou area are predominantly simple Uu, and the infection rate is much higher in women than in men, and josamycin, doxycycline and minocycline should be selected as priority drugs in clinical treatment.
  • [1]
    BORCHSENIUS S N, DAKS A, FEDOROVA O, et al. Effects of Mycoplasma infection on the host organism response via p53/NF-κB signaling[J]. J Cell Physiol, 2018, 234(1): 171-180. https://pubmed.ncbi.nlm.nih.gov/30146800/
    [2]
    BALKUS J E, MANHART L E, JENSEN J S, et al. Mycoplasma genitalium infection in Kenyan and US women[J]. Sex Transm Dis, 2018, 45(8): 514-521. doi: 10.1097/OLQ.0000000000000799
    [3]
    CAPOCCIA R, GREUB G, BAUD D. Mycoplasma, Ureaplasma, and Adverse Pregnancy Outcomes[J]. Infect Dis Obstet Gynecol, 2013, 26(3): 231-240. https://pubmed.ncbi.nlm.nih.gov/20706675/
    [4]
    乔蕾, 杨晶珍, 肖诚. 生殖道支原体感染对胚胎停育和反复自然流产的影响探讨[J]. 当代医学, 2018, 24(34): 104-106. doi: 10.3969/j.issn.1009-4393.2018.34.040
    [5]
    曹仁康, 王露娟, 杨靖, 等. 某生殖中心就诊不孕患者支原体感染及其药物敏感性研究[J]. 中华医院感染学杂志, 2019, 29(22): 3469-3472. https://www.cnki.com.cn/Article/CJFDTOTAL-ZHYY201922025.htm
    [6]
    WAITES K B, KATZ B, SCHELONKA R L. Mycoplasmas and ureaplasmas as neonatal pathogens[J]. Clin Microbiol Rev, 2005, 18(4): 757-789. doi: 10.1128/CMR.18.4.757-789.2005
    [7]
    刘小平, 徐安平, 苏琪, 等. 5 153例泌尿生殖道标本的解脲脲原体和人型支原体的检测[J]. 中华医院感染学杂志, 2004, 14(4): 465-467. doi: 10.3321/j.issn:1005-4529.2004.04.037
    [8]
    郭炽鹏, 陆春, 朱国兴. 解脲脲原体耐药性研究进展[J]. 微生物与感染, 2018, 13(4): 245-249. doi: 10.3969/j.issn.1673-6184.2018.04.008
    [9]
    邓淑贞. 克拉霉素治疗不同性别生殖道支原体感染疗效及不良反应的对比[J]. 海峡药学, 2016, 28(10): 112-113. doi: 10.3969/j.issn.1006-3765.2016.10.051
    [10]
    毛昱. 人型支原体感染状况及对大环内酯类药物耐药性研究[D]. 大连: 大连医科大学, 2007.
    [11]
    张冉, 吴移谋, 向斌, 等. 喹诺酮类药物诱导人型支原体耐药机理研究[J]. 中华检验医学杂志, 2000, 23(5): 273-275. doi: 10.3760/j:issn:1009-9158.2000.05.005
    [12]
    DOMINGUES D, TÁVORA TAVIRA L, DUARTE A, et al. Genital mycoplasmas in women attending a family planning clinic in Guiné-Bissau and their susceptibility to antimicrobial agents[J]. Acta Trop, 2003, 86(1): 19-24. doi: 10.1016/S0001-706X(03)00002-0
    [13]
    陈良善. 泌尿生殖道感染病原菌分布及药敏状况分析[J]. 实用临床医药杂志, 2020, 24(22): 66-69. doi: 10.7619/jcmp.202022019
    [14]
    耿见忠, 张军会, 王宇. 2016—2020年贵州地区女性生殖道支原体感染情况及药敏分析[J]. 检验医学与临床, 2021, 18(17): 2565-2569. doi: 10.3969/j.issn.1672-9455.2021.17.029
    [15]
    曾俊萍, 刘佳, 曾辛. 2016—2019年南昌地区泌尿生殖道支原体感染现状及药敏分析[J]. 检验医学与临床, 2021, 18(9): 1238-1241. doi: 10.3969/j.issn.1672-9455.2021.09.015
  • Related Articles

    [1]LI Ruibiao, REN Chengbo, WANG Cong, LI Yaru. Comparison of the efficacy of dosimetric parameters defined by different lung volume methods in predicting radiation pneumonitis in patients with non-small cell lung cancer[J]. Journal of Clinical Medicine in Practice, 2022, 26(19): 5-8, 13. DOI: 10.7619/jcmp.20221246
    [2]ZHOU Hui, SHAN Shucan. Dosimetry and passing rate of forward-intensity modulated radiation therapy and intensity modulated radiation therapy for left breast cancer patients with breast conserving surgery[J]. Journal of Clinical Medicine in Practice, 2021, 25(1): 15-18. DOI: 10.7619/jcmp.20200319
    [3]PAN Xiang, YANG Yi, HOU Yu, YUAN Meifang. Dosimetric differences of different radiation modes based on Monaco in postoperative intensity modulated radiotherapy of patients with left breast-conserving surgery for breast cancer[J]. Journal of Clinical Medicine in Practice, 2021, 25(1): 1-5. DOI: 10.7619/jcmp.20200621
    [4]YUAN Meifang, ZHAO Biao, YANG Yi, TANG Kewei, AN Yijun. Static intensity-modulated radiotherapy versus volumetric modulated arc therapy in dosimetric parameters of target area and organs at risk for middle thoracic esophageal cancer[J]. Journal of Clinical Medicine in Practice, 2020, 24(15): 21-24. DOI: 10.7619/jcmp.202015006
    [5]PAN Xiang, LI Ya, ZHU Sijin, YANG Yi. Dosimetry difference between field-in-field intensity modulated radiation therapy and fixed field inversely optimized intensity modulated radiation therapy in whole brain radiotherapy[J]. Journal of Clinical Medicine in Practice, 2019, 23(19): 12-16. DOI: 10.7619/jcmp.201919003
    [6]LU Yuting, WANG Jian, LIN Tao, SUI Jianfeng, YU Jingping, NI Xinye, SUN Suping. Dosimetry comparison between two different supraclavicular areas irradiation schedules for post-operation breast cancer and its influence on life quality[J]. Journal of Clinical Medicine in Practice, 2016, (19): 34-36. DOI: 10.7619/jcmp.201619010
    [7]LIU Wanjun, ZHANG Xizhi, LI Jun, HUA Wei, ZHANG Xianwen, CHEN Xuemei. Effects of dose calculation algorithm on dosiology of breast cancer patients with intensity modulated radiation therapy[J]. Journal of Clinical Medicine in Practice, 2016, (15): 28-32. DOI: 10.7619/jcmp.201615008
    [8]SONG Chengxia, WANG Jing. Dosimetric study of volumetric modulated arc therapy and intensity modulated radiation therapy in postoperative radiotherapy of cervical carcinoma[J]. Journal of Clinical Medicine in Practice, 2015, (23): 75-77,81. DOI: 10.7619/jcmp.201523023
    [9]LI Jinkai, CAO Yuandong, LI Caihong, WANG Peipei, SUN Xinchen. Application of volumetric modulated radiation therapy in the radiotherapy of patients with left breast cancer after breast-conserving surgery[J]. Journal of Clinical Medicine in Practice, 2015, (21): 59-62. DOI: 10.7619/jcmp.201521016
    [10]LI Danming, WANG Li, SUN Xinchen, MU Qingxia, PEI Zhongling. Dosimetric comparison between two volumetric modulated photon arc therapies for patients with breast cancer mastecomy[J]. Journal of Clinical Medicine in Practice, 2014, (16): 70-74. DOI: 10.7619/jcmp.201416020
  • Cited by

    Periodical cited type(2)

    1. 黄梦钰,王雅梅. 非编码RNA在口腔鳞状细胞癌耐药机制中的研究进展. 医学研究杂志. 2024(05): 22-26 .
    2. 王军成,兰彦平,赵岳阳,蒯涛,马东明,李敏. LINK-A RNAi慢病毒载体构建及其抑制U251胶质瘤细胞增殖的研究. 宁夏医学杂志. 2023(07): 577-580+572 .

    Other cited types(0)

Catalog

    Article views (235) PDF downloads (16) Cited by(2)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return